Country: Kýpur
Tungumál: gríska
Heimild: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
GLIMEPIRIDE
DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629
A10BB12
GLIMEPIRIDE
2MG
TABLETS
GLIMEPIRIDE (0093479971) 2MG
ORAL USE
Εθνική Διαδικασία
GLIMEPIRIDE
Νομικό καθεστώς: Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 30 TABS IN BLISTER(S) (280002601) 30 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται
COMPARATIVE TABLE ENGLISH VS GREEK PIL PACKAGE LEAFLET: INFORMATION FOR THE USER NAFURIL 1 MG TABLETS NAFURIL 2 MG TABLETS NAFURIL 3 MG TABLETS NAFURIL 4 MG TABLETS Glimepiride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What Nafuril is and what it is used for 2. What you need to know before you take Nafuril 3. How to take Nafuril 4. Possible side effects 5. How to store Nafuril 6. Contents of the pack and other information ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΤΟ ΧΡΉΣΤΗ NAFURIL 1 MG ΔΙΣΚΊΑ NAFURIL 2 MG ΔΙΣΚΊΑ NAFURIL 3 MG ΔΙΣΚΊΑ NAFURIL 4 MG ΔΙΣΚΊΑ Γλιμεπιρίδη ΔΙΑΒΆΣΤΕ ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ ΤΟ ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΠΡΙΝ ΑΡΧΊΣΕΤΕ ΝΑ ΠΑΊΡΝΕΤΕ ΑΥΤΌ ΤΟ ΦΆΡΜΑΚΟ, ΔΙΌΤΙ ΠΕΡΙΛΑΜΒΆΝΕΙ ΣΗΜΑΝΤΙΚΈΣ ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ. • Φυλάξτε αυτό το φύλλο οδηγιών χρήσης. Ίσως χρειαστεί να το διαβάσετε ξανά. • Εάν έχετε περαιτέρω απορίες, ρωτήστε το γιατρό ή το φαρμακοποιό σας. • Η συνταγή για αυτό το φάρμακο χορηγήθηκε αποκλειστικά για σας. Δεν πρέπει να δώσετε το φάρμακο σε άλλους. Μπορεί να τους προκαλέσει βλάβη, ακόμα και όταν τα συμπτώματα της ασθένειάς τους Lestu allt skjalið
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL PRODUCT Nafuril 1 mg Tablets Nafuril 2 mg Tablets Nafuril 3 mg Tablets Nafuril 4 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION For 1mg strength: Each tablet contains 1mg of glimepiride. For 2mg strength: Each tablet contains 2 mg of glimepiride. For 3mg strength: Each tablet contains 3 mg of glimepiride. For 4mg strength: Each tablet contains 4 mg of glimepiride. Excipients: Each tablet contains lactose monohydrate. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets For 1mg strength: White, beveled-edge capsule shaped, uncoated tablets For 2mg strength: White, beveled-edge capsule shaped, uncoated tablets with breakline on one side For 3mg strength: Yellow coloured, beveled-edge capsule shaped, uncoated tablets with breakline on one side For 4mg strength: Yellow coloured, flat beveled-edge, capsule shaped, uncoated tablets with breakline on one side 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Nafuril is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration 1 The basis for successful treatment of diabetes is a good diet, regular physical activity, as well as routine checks of blood and urine. Tablets or insulin can not compensate if the patient does not keep to the recommended diet. Posology Dose is determined by the results of blood and urinary glucose determinations. The starting dose is 1 mg glimepiride per day. If good control is achieved this dose should be used for maintenance therapy. For the different dose regimens appropriate strengths are available. If control is unsatisfactory the dose should be increased, based on the glycaemic control, in a stepwise manner with an interval of about 1 to 2 weeks between each step, to 2, 3 or 4 mg glimepiride per day. A dose of more than 4 mg glimepiride per day gives better results only in exceptional cases. The maximum recomme Lestu allt skjalið